View drug registration information details.

Items	Registration information
ID	656
No	656
Brand Name	ROSWIN 5 MG TABLETS
Ingredients	ROSUVASTATIN CALCIUM USP EQ.TO ROSUVASTATIN 5 MG
Dosage Form	FILM COATED TABLET
Primary Packaging	ALU-ALU BLISTER
Storage	STORE BELOW 30 C
Shelf Life	36 MONTHS
Pack Size	BOX OF 1 X 10'S
Dispensing Category	Prescription only
ATC Classification
Pharmaceutical Class	LIPID MODIFYING AGENTS
Indications	• adjunctive therapy to diet to reduce elevated total cholesterol (total C), LDL, apolipoprotein B (ApoB), non-HDL, and TG levels and to increase HDL in adults with primary hyperlipidemia or mixed dyslipidemia. • adjunctto reduce total C, LDL and ApoB levels in adolescents. • Who are at least 1 year after menarchy (women), 10 to 17 years with heterozygous familial hypercholesterolemia (HeFH) and in those who, after dietary treatment, have an LDL >190mg/dl or. • >160mg/dl and there is a positive family history of premature cardiovascular disease (CVD) or two or more other CVD risk factors. • For the treatment of hypertriglyceridemia in adults. • For the treatment of primary dysbetalipoproteinemia (type III hyperlipoproteinemia). •Adjunct therapy to other lipid-lowering treatments (e.g., LDL Apheresis) or alone if such treatments are not available to reduce LDL, total C, and ApoB in adults with hypercholesterolemia homozygous familial (HoFH). • Adjunct to slow the progression of atherosclerosis in adults as • Part of a treatment strategy aimed at lowering total C and LDL to target levels. • Reduces the risk of myocardial infarction, stroke and artery Revascularization procedures in people at increased risk of cardiovascular disease.
Contraindications
Side Effects
Unit Price
EDL	Yes
Description	Pink oval biconvex film coated tablet, engraved M/D on one side and plain from other side
Note	ONLINE
License Owner	EXAMED CO.,LTD
Manufacturer	MARTIN DOW LTD
Country	PAKISTAN
Import Registration No	48992
Import Registration Date	2008-02-19
Activity	CERTIFICATE RELEASED
Applied Date	2024-07-19
FDD Registration No	01 I 5856/25
FDD Registration Date	2025-01-23
Expiry Date	2030-01-22

Back to drug list